Molecular mechanisms of programmed necrosis in the ischemic retina
缺血性视网膜程序性坏死的分子机制
基本信息
- 批准号:10672428
- 负责人:
- 金额:$ 38.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:AblationAccidentsAffectAnimal ModelApoptosisApoptoticAttentionBindingBiochemicalBiologicalCASP8 geneCaspaseCell DeathCell SurvivalCell membraneCellsClinicalComplexDNA DamageDataDeubiquitinationEventFailureFeedbackFunctional disorderGeneticInduction of ApoptosisInflammatory ResponseInjuryIschemiaLiteratureMAPK8 geneMediatingMediatorMembraneMitochondriaMolecularMolecular ConformationNADPH OxidaseNecrosisNeuronsOsmosisOxidative StressPathway interactionsPatientsPoly(ADP-ribose) PolymerasesPolymeraseProductionProteinsPublished CommentPublishingQuality of lifeReactive Oxygen SpeciesReperfusion InjuryReperfusion TherapyResearchRespirationRetinaRetinal DegenerationRetinal Ganglion CellsRoleSignal TransductionSwellingTNF geneTechniquesTestingTimeTumor Necrosis Factor ReceptorUbiquitinationVisionVisual impairmentcell typeexperimental studyfunctional statusmulticatalytic endopeptidase complexneurotoxicnovel therapeutic interventionoxidative DNA damagepreventresponseretinal damageretinal ischemiaretinal neuronretinal stimulation
项目摘要
PROJECT SUMMARY
Retinal ischemia-reperfusion (IR) injury is a common cause of visual impairment worldwide, affecting both
patients' quality of life and functional status. Retinal ganglion cell (RGC) survival is critical for vision. However,
these retinal neurons are exquisitely sensitive and many of them undergo necrosis and apoptosis after IR.
Since RGC apoptosis is executed by programmed mechanisms and can be regulated, significant attention has
been given to this type of cell death. At the same time, RGC necrosis did not receive nearly enough
consideration, because it was viewed as an accidental and unregulated cellular event. We now know that
necrosis, like apoptosis, can be executed by programmed mechanisms. This form of necrotic cell death is
called necroptosis. Our published data and literature indicate that RGC necroptosis contributes to IR-induced
retinal injury through direct loss of RGCs and induction of associated inflammatory responses. Therefore, since
RGC necroptosis is executed by programmed mechanisms and can be regulated, this field of research is of
great importance. However, the signaling cascades, which regulate IR-induced RGC necroptosis, still remain
unknown. The long-term objective of this project is to identify the signaling cascades that regulate RGC
necroptosis after IR. Based on our published data, preliminary studies and published literature, we proposed a
molecular mechanism of IR-induced RGC necroptosis. We suggested that IR-induced Tnf signaling in RGCs
facilitates formation of a positive-feedback loop for the sustained production of reactive oxygen species (ROS),
which promotes poly (ADP-ribose) polymerase 1 (Parp1) over-activation due to significant oxidative DNA
damage. Significant Parp1 over-activation in RGCs mediates ATP depletion, leading to subsequent energy
failure, which results in cellular dysfunction and eventually in loss of RGC membrane integrity (necrosis). We
will employ a wide range of biochemical, molecular and cell biological techniques as well as animal models to
verify the proposed molecular mechanism of IR-induced RGC necroptosis in hypothesis-driven mechanistic
experiments outlined in the following specific aims: 1) to test the hypothesis that Tnf signaling promotes IR-
induced RGC necroptosis; 2) to test the hypothesis that IR-induced RGC necroptosis is promoted by formation
of a positive-feedback loop for sustained ROS production in a Tnf signaling-dependent manner; 3) to test the
hypothesis that RGC necroptosis is a result of ATP depletion caused by Parp1 over-activation after IR. Thus,
since treatment for IR is limited in part because of a lack of understanding of the molecular events leading to
RGC death, a greater understanding of RGC necroptosis after IR will lead to new therapeutic strategies for this
important and difficult to treat condition.
项目摘要
视网膜缺血再灌注(IR)损伤是全球视觉障碍的常见原因,两者都影响
患者的生活质量和功能状况。视网膜神经节细胞(RGC)存活对于视力至关重要。然而,
这些视网膜神经元非常敏感,其中许多神经元在IR后发生坏死和凋亡。
由于RGC凋亡是通过编程机制执行的,并且可以受到调节,因此非常关注
被赋予了这种类型的细胞死亡。同时,RGC坏死的接收不够
考虑因素,因为它被视为意外和不受管制的细胞事件。我们现在知道
坏死,例如凋亡,可以通过编程机制执行。这种坏死细胞死亡的形式是
称为坏死性。我们发表的数据和文献表明RGC坏死作用有助于IR诱导
通过直接丧失RGC和相关炎症反应的诱导,视网膜损伤。因此,自从
RGC坏死作用是通过编程机制执行的,可以受到调节,这一研究领域是
非常重视。然而,调节IR诱导的RGC坏死的信号级联反应仍然存在
未知。该项目的长期目标是确定调节RGC的信号传导级联
IR后坏死性。根据我们发布的数据,初步研究和发表的文献,我们提出了一个
IR诱导的RGC坏死的分子机制。我们建议IR诱导的RGC中的TNF信号传导
促进形成一个正反馈回路,以持续产生活性氧(ROS),
由于明显的氧化DNA而促进聚(ADP-核糖)聚合酶1(PARP1)过度激活
损害。 RGC中的显着PARP1过度激活介导ATP耗竭,导致随后的能量
失败,导致细胞功能障碍,最终导致RGC膜完整性丧失(坏死)。我们
将采用多种生化,分子和细胞生物学技术以及动物模型
验证在假设驱动的机理中IR诱导的RGC坏死的拟议分子机制
在以下特定目的中概述的实验:1)测试TNF信号促进IR-的假设
诱导RGC坏死性; 2)检验以下假设,即通过形成促进IR诱导的RGC坏死作用
以TNF信号依赖性方式进行持续ROS产生的阳性反馈回路; 3)测试
假设RGC坏死性是IR后PARP1过度激活引起的ATP耗竭的结果。因此,
由于对IR的治疗受到限制,部分原因是缺乏对分子事件的了解
RGC死亡,对IR后的RGC坏死病有更多的了解,将导致新的治疗策略
重要且难以治疗状况。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dmitry V Ivanov其他文献
Dmitry V Ivanov的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dmitry V Ivanov', 18)}}的其他基金
The role of the TET-dependent DNA demethylation pathway in photoreceptor development and pathology
TET依赖性DNA去甲基化途径在光感受器发育和病理学中的作用
- 批准号:
10709133 - 财政年份:2023
- 资助金额:
$ 38.38万 - 项目类别:
Molecular mechanisms of programmed necrosis in the ischemic retina
缺血性视网膜程序性坏死的分子机制
- 批准号:
10268702 - 财政年份:2021
- 资助金额:
$ 38.38万 - 项目类别:
Molecular mechanisms of programmed necrosis in the ischemic retina
缺血性视网膜程序性坏死的分子机制
- 批准号:
10462664 - 财政年份:2021
- 资助金额:
$ 38.38万 - 项目类别:
Mechanisms of toll-like receptor-mediated neurotoxicity in the ischemic retina
Toll样受体介导的缺血性视网膜神经毒性机制
- 批准号:
9207596 - 财政年份:2017
- 资助金额:
$ 38.38万 - 项目类别:
Role of toll-like receptor signaling in retinal ischemia
Toll样受体信号传导在视网膜缺血中的作用
- 批准号:
8448079 - 财政年份:2012
- 资助金额:
$ 38.38万 - 项目类别:
Role of toll-like receptor signaling in retinal ischemia
Toll样受体信号传导在视网膜缺血中的作用
- 批准号:
8272305 - 财政年份:2012
- 资助金额:
$ 38.38万 - 项目类别:
Role of toll-like receptor signaling in retinal ischemia
Toll样受体信号传导在视网膜缺血中的作用
- 批准号:
8634102 - 财政年份:2012
- 资助金额:
$ 38.38万 - 项目类别:
The role of cell death signals in retinal ischemia
细胞死亡信号在视网膜缺血中的作用
- 批准号:
7872225 - 财政年份:2010
- 资助金额:
$ 38.38万 - 项目类别:
The role of cell death signals in retinal ischemia
细胞死亡信号在视网膜缺血中的作用
- 批准号:
8035310 - 财政年份:2010
- 资助金额:
$ 38.38万 - 项目类别:
相似国自然基金
事故容错燃料表面腐蚀对压水堆流动传热的影响研究
- 批准号:
- 批准年份:2022
- 资助金额:55 万元
- 项目类别:面上项目
事故容错燃料表面腐蚀对压水堆流动传热的影响研究
- 批准号:12275088
- 批准年份:2022
- 资助金额:55.00 万元
- 项目类别:面上项目
疫情下城市慢行交通事故影响机理与建模研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
疫情下城市慢行交通事故影响机理与建模研究
- 批准号:52102406
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
事故与导航风险驾驶行为数据融合的多维度路网结构特征交通安全影响研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Metabolic impairment plays a critical role in radiation-induced T cell immune dysfunction
代谢损伤在辐射诱导的 T 细胞免疫功能障碍中起着关键作用
- 批准号:
10474738 - 财政年份:2022
- 资助金额:
$ 38.38万 - 项目类别:
Metabolic impairment plays a critical role in radiation-induced T cell immune dysfunction
代谢损伤在辐射诱导的 T 细胞免疫功能障碍中起着关键作用
- 批准号:
10668368 - 财政年份:2022
- 资助金额:
$ 38.38万 - 项目类别:
Fetal cerebral arteries and prenatal alcohol exposure
胎儿脑动脉和产前酒精暴露
- 批准号:
10590708 - 财政年份:2022
- 资助金额:
$ 38.38万 - 项目类别:
Essential Role for SPG7 in Mitochondrial Permeability Transition Pore Assembly and Function
SPG7 在线粒体渗透性转变孔组装和功能中的重要作用
- 批准号:
10241316 - 财政年份:2020
- 资助金额:
$ 38.38万 - 项目类别:
Novel Long Acting rhTSH Superagonist Analogs for Improved Diagnostic Imaging, Thyroglobulin Stimulation and Therapy of Thyroid Cancer.
新型长效 rhTSH 超级激动剂类似物,可改善甲状腺癌的诊断成像、甲状腺球蛋白刺激和治疗。
- 批准号:
9559746 - 财政年份:2018
- 资助金额:
$ 38.38万 - 项目类别: